AR and pachyonychia congenita: Inspired by their critical role in PC treatment and the optimal anti-tumor effects of the combination of chemotherapy and RNA interference, we speculate that the combined therapy of AR siRNA and DTX is likely to have an enhanced therapeutic effect on PC.